Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACE Combination Therapy in Advanced NSCLC
NCT07738367Phase 2Enrolling by invitation
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by Fujian Medical University Cancer Hospital. Primary endpoints: Local Time to Progression up to 24 months and Treatment-Related Adverse Events. Started Apr 2026; status: enrolling by invitation.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07738367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738367.